Brought to you by 
Pfizer teams up with MD Anderson in oncology
09 Nov 2021
Executive Summary
Under a three-year collaboration, Pfizer Inc. will work with the University of Texas’ MD Anderson Cancer Center’s Moon Shots Program to advance immunological cancer drugs, identify new combination therapies, and develop biomarkers to monitor treatment.
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
-
Biotechnology
- Immuno-Oncology
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Pfizer teams up with MD Anderson in oncology
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice